ALESSANDRIA, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 308
EU - Europa 133
AS - Asia 97
AF - Africa 3
SA - Sud America 1
Totale 542
Nazione #
US - Stati Uniti d'America 302
IT - Italia 54
SG - Singapore 49
CN - Cina 34
IE - Irlanda 29
SE - Svezia 25
DE - Germania 9
CA - Canada 6
ID - Indonesia 4
BE - Belgio 3
PH - Filippine 3
UA - Ucraina 3
EG - Egitto 2
FI - Finlandia 2
FR - Francia 2
GR - Grecia 2
JP - Giappone 2
TR - Turchia 2
VN - Vietnam 2
BR - Brasile 1
GB - Regno Unito 1
IN - India 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 542
Città #
Chandler 90
Singapore 44
Dublin 29
Beijing 14
Nyköping 12
Torino 10
Guangzhou 9
Princeton 8
Dearborn 6
Medford 6
Ashburn 5
Ottawa 5
Houston 4
New York 4
Turin 4
Wilmington 4
Barete 3
Boardman 3
Boston 3
Brussels 3
Hangzhou 3
Jacksonville 3
Jakarta 3
Redwood City 3
Alexandria 2
Athens 2
Bologna 2
Esslingen am Neckar 2
Falls Church 2
Florence 2
Freiburg 2
Hefei 2
Istanbul 2
Lappeenranta 2
Norwalk 2
Prata Di Pordenone 2
Riverton 2
San Michele Al Tagliamento 2
Santa Clara 2
Shanghai 2
Varese 2
Woodbridge 2
Afragola 1
Alessandria 1
Ann Arbor 1
Bordeaux 1
Dong Ket 1
Grugliasco 1
Guiyang 1
Hebei 1
Jenera 1
Nagold 1
Nardò 1
Niigata 1
Padova 1
Radeberg 1
San Mateo 1
Seattle 1
São Paulo 1
Toronto 1
Trento 1
Vicenza 1
Washington 1
Wenzhou 1
Yekaterinburg 1
Totale 337
Nome #
Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis 76
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis 71
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 67
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology 58
Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease 57
Terlipressin vs noradrenalin for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: 1 5-year retrospective analysis 48
Liver involvement in adult-onset Still's disease: our experience in a third level liver unit and review of the literature 47
Assessment of glomerular filtration rate in patients with cirrhosis: available tools and perspectives 36
Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function 14
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis 13
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 12
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis 11
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis 10
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial 10
The Use of Rifaximin in Patients With Cirrhosis 9
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 8
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium 8
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 6
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 5
null 4
Totale 570
Categoria #
all - tutte 3.264
article - articoli 0
book - libri 0
conference - conferenze 714
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 3 3 10 4 1 0 3 3 1
2020/202153 6 2 19 1 10 1 0 3 4 0 1 6
2021/202294 0 2 4 1 10 5 2 1 4 6 36 23
2022/2023211 23 18 10 38 10 38 19 12 17 5 16 5
2023/2024105 20 26 11 5 2 10 1 1 5 5 2 17
2024/202560 3 14 40 3 0 0 0 0 0 0 0 0
Totale 570